Lattice Biologics (TSXV:LBL.H) EPS (Basic) : C$-0.01 (TTM As of Jun. 2021)

View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics EPS (Basic)?

Lattice Biologics's basic earnings per share (Basic EPS) for the three months ended in Jun. 2021 was C$0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2021 was C$-0.01.

Lattice Biologics's EPS (Diluted) for the three months ended in Jun. 2021 was C$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 was C$-0.01.

Lattice Biologics's EPS without NRI for the three months ended in Jun. 2021 was C$0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2021 was -0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Lattice Biologics EPS (Basic) Historical Data

The historical data trend for Lattice Biologics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics EPS (Basic) Chart

Lattice Biologics Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Sep16

Sep17

Sep18

Sep19

Sep20

EPS (Basic)

Get a 7-Day Free Trial

-0.21

-0.03

-0.01

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
EPS (Basic)	Get a 7-Day Free Trial															-	-	-	-	-

Lattice Biologics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Lattice Biologics's Basic EPS for the fiscal year that ended in Sep. 2020 is calculated as

Basic EPS (A: Sep. 2020 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.962	-	0)	/	102.576
	=	-0.02

Lattice Biologics's Basic EPS for the quarter that ended in Jun. 2021 is calculated as

Basic EPS (Q: Jun. 2021 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.032	-	0)	/	128.218
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01

Lattice Biologics (TSXV:LBL.H) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Lattice Biologics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (TSXV:LBL.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714

Website

http://www.latticebiologics.com

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines